Published in Biochemistry on July 07, 2009
A boost for the emerging field of RNA nanotechnology. ACS Nano (2011) 1.17
Genomic SELEX: a discovery tool for genomic aptamers. Methods (2010) 0.93
Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets. Biomed Res Int (2015) 0.88
Aptamer-based therapeutics: new approaches to combat human viral diseases. Pharmaceuticals (Basel) (2013) 0.86
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy. Curr Genomics (2015) 0.81
HAPIscreen, a method for high-throughput aptamer identification. J Nanobiotechnology (2011) 0.80
HIV-1 drug discovery: targeting folded RNA structures with branched peptides. Org Biomol Chem (2015) 0.77
Aptamers against pathogenic microorganisms. Crit Rev Microbiol (2015) 0.75
Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology (2006) 4.70
Molecular basis for target RNA recognition and cleavage by human RISC. Cell (2007) 4.40
The impact of target site accessibility on the design of effective siRNAs. Nat Biotechnol (2008) 2.51
RNA chaperones, RNA annealers and RNA helicases. RNA Biol (2007) 2.41
Conditional gene expression by controlling translation with tetracycline-binding aptamers. Nucleic Acids Res (2003) 1.57
Dissecting RNA chaperone activity. RNA (2007) 1.55
The C-terminal domain of Escherichia coli Hfq is required for regulation. Nucleic Acids Res (2007) 1.55
Monitoring genomic sequences during SELEX using high-throughput sequencing: neutral SELEX. PLoS One (2010) 1.28
RNA chaperone StpA loosens interactions of the tertiary structure in the td group I intron in vivo. Genes Dev (2002) 1.23
Determination of thermodynamic parameters for HIV DIS type loop-loop kissing complexes. Nucleic Acids Res (2004) 1.21
A boost for the emerging field of RNA nanotechnology. ACS Nano (2011) 1.17
RNA chaperone activity of large ribosomal subunit proteins from Escherichia coli. RNA (2004) 1.11
Genomic systematic evolution of ligands by exponential enrichment (Genomic SELEX) for the identification of protein-binding RNAs independent of their expression levels. Nat Protoc (2006) 1.09
Isolation of specific RNA-binding proteins using the streptomycin-binding RNA aptamer. Nat Protoc (2006) 1.07
RNA chaperone activity and RNA-binding properties of the E. coli protein StpA. Nucleic Acids Res (2007) 1.07
The double-stranded transcriptome of Escherichia coli. Proc Natl Acad Sci U S A (2014) 1.06
Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Res (2003) 1.06
Monitoring intermediate folding states of the td group I intron in vivo. EMBO J (2002) 1.03
Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides. Biochemistry (2006) 1.02
RNA chaperone activity of protein components of human Ro RNPs. RNA (2005) 1.01
Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex. Proc Natl Acad Sci U S A (2008) 0.99
Isolation of small RNA-binding proteins from E. coli: evidence for frequent interaction of RNAs with RNA polymerase. RNA Biol (2008) 0.98
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1. Nucleic Acids Res (2004) 0.97
Apical loop-internal loop interactions: a new RNA-RNA recognition motif identified through in vitro selection against RNA hairpins of the hepatitis C virus mRNA. Biochemistry (2002) 0.97
Kissing complex-mediated dimerisation of HIV-1 RNA: coupling extended duplex formation to ribozyme cleavage. Nucleic Acids Res (2003) 0.96
Selective inhibitory DNA aptamers of the human RNase H1. Nucleic Acids Res (2003) 0.95
Stabilities of HIV-1 DIS type RNA loop-loop interactions in vitro and in vivo. Nucleic Acids Res (2006) 0.95
Genomic SELEX: a discovery tool for genomic aptamers. Methods (2010) 0.93
Aptamers: a new class of oligonucleotides in the drug discovery pipeline? Curr Opin Pharmacol (2009) 0.93
Transient RNA-protein interactions in RNA folding. FEBS J (2011) 0.92
Influence of RNA structural stability on the RNA chaperone activity of the Escherichia coli protein StpA. Nucleic Acids Res (2005) 0.92
Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription. Proc Natl Acad Sci U S A (2002) 0.91
2'-O-methyl-RNA hairpins generate loop-loop complexes and selectively inhibit HIV-1 Tat-mediated transcription. Biochemistry (2002) 0.90
Folding problems of the 5' splice site containing the P1 stem of the group I thymidylate synthase intron: substrate binding inhibition in vitro and mis-splicing in vivo. J Biol Chem (2002) 0.90
Monovalent ion dependence of neomycin B binding to an RNA aptamer characterized by spectroscopic methods. Chembiochem (2007) 0.90
Coupling RNA annealing and strand displacement: a FRET-based microplate reader assay for RNA chaperone activity. Biotechniques (2007) 0.88
Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication. RNA Biol (2006) 0.87
Use of dynamic combinatorial chemistry for the identification of covalently appended residues that stabilize oligonucleotide complexes. Angew Chem Int Ed Engl (2004) 0.87
SELEX and dynamic combinatorial chemistry interplay for the selection of conjugated RNA aptamers. Org Biomol Chem (2006) 0.87
NMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA-modified aptamer. Nucleic Acids Res (2007) 0.86
Determinants of apical loop-internal loop RNA-RNA interactions involving the HCV IRES. Biochem Biophys Res Commun (2004) 0.85
Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA. Biochemistry (2005) 0.83
Nucleic acids targeted to drugs: SELEX against a quadruplex ligand. Biochimie (2011) 0.83
Study of E. coli Hfq's RNA annealing acceleration and duplex destabilization activities using substrates with different GC-contents. Nucleic Acids Res (2012) 0.83
LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1. Blood Cells Mol Dis (2007) 0.83
Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity. Oligonucleotides (2007) 0.82
Aptamer structures: a preview into regulatory pathways? Chem Biol (2003) 0.82
Systematic screening of LNA/2'-O-methyl chimeric derivatives of a TAR RNA aptamer. FEBS Lett (2007) 0.82
The RNA annealing mechanism of the HIV-1 Tat peptide: conversion of the RNA into an annealing-competent conformation. Nucleic Acids Res (2011) 0.82
A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors. Nucleic Acids Res (2008) 0.81
In vitro selection of DNA aptamers against the HIV-1 TAR RNA hairpin. Antisense Nucleic Acid Drug Dev (2002) 0.81
Characterization of the kinetics of RNA annealing and strand displacement activities of the E. coli DEAD-box helicase CsdA. RNA Biol (2013) 0.81
Mechanisms of StpA-mediated RNA remodeling. RNA Biol (2010) 0.80
Deciphering aromatic oligoamide foldamer-DNA interactions. Angew Chem Int Ed Engl (2011) 0.80
HAPIscreen, a method for high-throughput aptamer identification. J Nanobiotechnology (2011) 0.80
Bimodal loop-loop interactions increase the affinity of RNA aptamers for HIV-1 RNA structures. Biochemistry (2006) 0.80
In vitro selection procedures for identifying DNA and RNA aptamers targeted to nucleic acids and proteins. Methods Mol Biol (2005) 0.79
(99m)Tc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9. Bioconjug Chem (2012) 0.79
RNA Biology. Letter from the editor. RNA Biol (2013) 0.79
RNA chaperone activity of L1 ribosomal proteins: phylogenetic conservation and splicing inhibition. Nucleic Acids Res (2007) 0.79
Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions. Methods Mol Biol (2011) 0.78
Assaying RNA chaperone activity in vivo in bacteria using a ribozyme folding trap. Nat Protoc (2006) 0.78
Aptamers as imaging agents. Expert Opin Med Diagn (2010) 0.77
Anti-HIV activity of steric block oligonucleotides. Ann N Y Acad Sci (2006) 0.77
A yeast RNA-hybrid system for the detection of RNA-RNA interactions in vivo. RNA (2005) 0.77
Finding aptamers and small ribozymes in unexpected places. Wiley Interdiscip Rev RNA (2011) 0.77
Riboswitches based on kissing complexes for the detection of small ligands. Angew Chem Int Ed Engl (2014) 0.76
Advances in binder identification and characterisation: the case of oligonucleotide aptamers. N Biotechnol (2011) 0.76
Regulating mRNA translation with a kiss. Nucleic Acids Symp Ser (Oxf) (2008) 0.76
Aptamers targeting RNA molecules. Methods Mol Biol (2009) 0.76
Identification and detection of RNA-RNA interactions using the yeast RNA hybrid system. Nat Protoc (2006) 0.76
Functional repeat-derived RNAs often originate from retrotransposon-propagated ncRNAs. Wiley Interdiscip Rev RNA (2014) 0.75
An improved design of the kissing complex-based aptasensor for the detection of adenosine. Anal Bioanal Chem (2015) 0.75
Inhibition of pre-mRNA splicing by a synthetic Blom7α-interacting small RNA. PLoS One (2012) 0.75
[Hommage to Professor Claude Hélène]. Bull Cancer (2003) 0.75
Encapsidation of RNA-polyelectrolyte complexes with amphiphilic block copolymers: toward a new self-assembly route. J Am Chem Soc (2012) 0.75
RNA techniques for bacteria. Curr Opin Microbiol (2007) 0.75
Nucleic acid aptamers. Methods (2016) 0.75
Double duty. Nat Struct Mol Biol (2004) 0.75
Comparative studies of tricyclo-DNA- and LNA-containing oligonucleotides as inhibitors of HIV-1 gene expression. Nucleosides Nucleotides Nucleic Acids (2007) 0.75
Aptamer-mediated nanoparticle interactions: from oligonucleotide-protein complexes to SELEX screens. Methods Mol Biol (2015) 0.75